Inmode LtdINMD
Price$14.05Intrinsic value$12.1913% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $12.19median of 5 methods · middle span $10-$15based on filings through 31 Dec 2025
Market Price $14.05Price as of 1 Oct 2026
Margin of Safety -13.3%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: -10.2% (near-term consensus, capped) · years 2–5: -4.2%/yr (balance of the path).-5.4% per year
Years 6–10: glide to demonstrated growth own history 23.7%, capped at 20%
Per-year rates
Yr 6-2.8%Yr 7-1.3%Yr 80.1%Yr 91.6%Yr 103.0%
-4.2% → 3.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 113.0%Yr 123.0%Yr 133.0%Yr 143.0%Yr 153.0%Yr 163.0%Yr 173.0%Yr 183.0%Yr 193.0%Yr 203.0%
3.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)23.7%
Discount rate (cost of equity) 12.0%
Volatility vs market (adjusted beta)1.57

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetInmode LtdINMDHealth Care
Valuation
P/E9.8×
P/S2.2×
P/B1.4×
EV / Revenue1.4×
EV / EBITDA4.1×
Profitability
Gross margin75.0%
Operating margin12.3%
Net margin25.3%
FCF margin22.7%
Returns
ROE13.7%
ROA12.2%
ROIC24.6%
Growth
Revenue growth (YoY)-6.2%
5-yr fwd EPS growth-3.3%
Financial strength
Debt / Equity0.00×
Current ratio9.88×
Altman Z-Score9.6
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.